United States · Venture startup
5 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$30Mraised across 5 rounds since 2010, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $3.1M sold, first sale Apr 2015
Canaan
ARCH Venture Partners
Versant Ventures
MPM Capital
Alexandria Real Estate EquitiesReported by finsmes.comSEC filing: $4.0M sold, first sale Mar 2013
Reported by finsmes.comSEC filing: $4.0M sold, first sale Mar 2013
No investor was named in the report.
Reported by sec.govSEC filing: $12M sold, first sale Aug 2011
Reported by xconomy.comSEC filing: $1.5M sold, first sale Mar 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
CanaanARCH Venture PartnersMPM CapitalAlexandria Real Estate EquitiesHealthCare VenturesAmgen
SVB CapitalVersant Ventures
MidCap FinancialZenyaku KogyoMissing a round, or an investor who was in one? Tell us.
Theraclone Sciences's investors include Canaan, ARCH Venture Partners, MPM Capital, Alexandria Real Estate Equities and HealthCare Ventures, and 5 more on record.
Theraclone Sciences has raised $30M across 5 rounds since 2010.
Theraclone Sciences's most recent round was a Venture of $3.1M in May 2015.
Theraclone Sciences's largest round on record is $12M (Series B), in Nov 2011.
Theraclone Sciences's first round on record, in Mar 2010, was backed by Canaan, ARCH Venture Partners and MPM Capital and 3 others.
Theraclone Sciences's latest named round is a Venture, in May 2015.
Theraclone Sciences is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
